Evidence map›Paper›PMID 33524389›Full record

ArticleThe Journal of biological chemistry

Structure-function studies of the C3/C5 epimerases and C4 reductases of the Campylobacter jejuni capsular heptose modification pathways.

Heba Barnawi, Laura Woodward, Natalie Fava, Mikhail Roubakha, Steve D Shaw, Chelsea Kubinec, James H Naismith, Carole Creuzenet

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Biosynthesis of UDP-α-Biochemistry · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Biosynthesis of d-Biochemistry · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Heba BarnawiDepartment of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada.
Laura WoodwardBiomedical Sciences Research Complex, St Andrews University, St Andrews, UK.
Natalie FavaDepartment of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada.
Mikhail RoubakhaDepartment of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada.
Steve D ShawDepartment of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada.
Chelsea KubinecDepartment of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada.
James H NaismithBiomedical Sciences Research Complex, St Andrews University, St Andrews, UK; Rosalind Franklin Institute, Research Complex at Harwell, Harwell Campus, Didcot, UK; Division of Structural Biology, Oxford University, Oxford, UK. Electronic address: naismith@strubi.ox.ac.uk.
Carole CreuzenetDepartment of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada. Electronic address: ccreuzen@uwo.ca.
Western University · CAUniversity of St Andrews · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

Many bacteria produce polysaccharide-based capsules that protect them from environmental insults and play a role in virulence, host invasion, and other functions. Understanding how the polysaccharide components are synthesized could provide new means to combat bacterial infections. We have previously characterized two pairs of homologous enzymes involved in the biosynthesis of capsular sugar precursors GDP-6-deoxy-D-altro-heptose and GDP-6-OMe-L-gluco-heptose in Campylobacter jejuni. However, the substrate specificity and mechanism of action of these enzymes-C3 and/or C5 epimerases DdahB and MlghB and C4 reductases DdahC and MlghC-are unknown. Here, we demonstrate that these enzymes are highly specific for heptose substrates, using mannose substrates inefficiently with the exception of MlghB. We show that DdahB and MlghB feature a jellyroll fold typical of cupins, which possess a range of activities including epimerizations, GDP occupying a similar position as in cupins. DdahC and MlghC contain a Rossman fold, a catalytic triad, and a small C-terminal domain typical of short-chain dehydratase reductase enzymes. Integrating structural information with site-directed mutagenesis allowed us to identify features unique to each enzyme and provide mechanistic insight. In the epimerases, mutagenesis of H67, D173, N121, Y134, and Y132 suggested the presence of alternative catalytic residues. We showed that the reductases could reduce GDP-4-keto-6-deoxy-mannulose without prior epimerization although DdahC preferred the pre-epimerized substrate and identified T110 and H180 as important for substrate specificity and catalytic efficacy. This information can be exploited to identify inhibitors for therapeutic applications or to tailor these enzymes to synthesize novel sugars useful as glycobiology tools.

Indexed as

Bacterial ProteinsCampylobacter InfectionsCampylobacter jejuniHeptosesHumansOxidoreductasesProtein ConformationRacemases and EpimerasesSubstrate SpecificityBacterial ProteinsHeptosesOxidoreductasesRacemases and EpimerasesCampylobacter jejunicapsuleepimeraseheptosereductase

Identifiers

PMID33524389
PMCPMC7949155
OpenAlexW3127908689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.